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Background
The Health Belief Model provides a framework to under-
stand motivators for volunteering for medical research.
Motivators can take the form of social benefits, including
macrosocial (pertaining to one’s greater society), mesoso-
cial (pertaining to one’s larger social world), and microso-
cial (pertaining to one’s immediate social network).
Personal benefits can be sub-divided into psychological,
physical, and financial well-being. In this systematic review
of review articles, we extend our conceptual framework
from motivators regarding participation in HIV vaccine
trials to another life-threatening disease, cancer.
Methods
In 2012, two people independently searched the
Cochrane Database for Systematic Reviews, Pubmed,
Embase, and Google Scholar to identify review articles
examining cancer trial motivators to participation.
Search terms were: “cancer”, “oncology”, “cancer trials”,
“oncology trials”, “clinical trials”, “medical research”,
“willingness to participate”, “motivators”, “incentives”.
Review articles were also retrieved from our search
examining barriers to participation in cancer research
and from bibliographic references.
Results
We retrieved 12 review articles from 2000-2012 examin-
ing motivators to participation in cancer trials. Personal
benefits were most often psychological such as “coping
with symptoms”. Social benefits included “advancing
research”, “helping other cancer patients”, and “for their
family”. These categories also apply well in HIV vaccine
trials. Personal/psychological benefits are most com-
monly cited as motivators for both types of research. In
cancer research, “coping with symptoms” and “extending
life expectancy” were motivators; in HIV vaccine trials, it
was to “reduce the risk of becoming HIV positive”.
Conclusion
While specific motivators vary between considerations
of cancer research and HIV vaccine trials, these motiva-
tors fall into similar categories at similar frequencies.
Personal / psychological benefits are most common in
each. Altruistic factors found at a macrosocial level out-
number factors relevant to more proximal levels, such
as family and other patients. Participant recruitment
must be mindful of these categories of motivators for
both HIV vaccine and cancer research.
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